Kingsview Wealth Management LLC grew its stake in shares of Morgan Stanley (NYSE:MS – Free Report) by 18.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,616 shares of the financial services provider’s stock after acquiring an additional 1,025 shares during the period. Kingsview Wealth Management LLC’s holdings in Morgan Stanley were worth $690,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of the stock. Opal Wealth Advisors LLC acquired a new position in Morgan Stanley in the 2nd quarter worth about $25,000. POM Investment Strategies LLC grew its stake in shares of Morgan Stanley by 1,147.6% in the 2nd quarter. POM Investment Strategies LLC now owns 262 shares of the financial services provider’s stock valued at $25,000 after buying an additional 241 shares in the last quarter. Bank & Trust Co acquired a new position in Morgan Stanley in the second quarter worth approximately $26,000. Northwest Investment Counselors LLC bought a new position in Morgan Stanley during the third quarter valued at approximately $26,000. Finally, Bbjs Financial Advisors LLC acquired a new stake in Morgan Stanley in the second quarter valued at approximately $29,000. 84.19% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Stephen J. Luczo sold 60,000 shares of the firm’s stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $119.17, for a total value of $7,150,200.00. Following the transaction, the director now owns 138,363 shares of the company’s stock, valued at $16,488,718.71. This trade represents a 30.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.24% of the company’s stock.
Analyst Ratings Changes
View Our Latest Analysis on MS
Morgan Stanley Trading Down 0.1 %
Shares of MS stock opened at $131.20 on Thursday. Morgan Stanley has a 12-month low of $76.33 and a 12-month high of $136.24. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 3.14. The company has a 50 day moving average of $118.10 and a 200-day moving average of $105.96. The firm has a market cap of $211.37 billion, a P/E ratio of 19.97, a PEG ratio of 1.24 and a beta of 1.34.
Morgan Stanley (NYSE:MS – Get Free Report) last released its quarterly earnings data on Wednesday, October 16th. The financial services provider reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.31. The firm had revenue of $15.38 billion during the quarter, compared to analyst estimates of $14.27 billion. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. Sell-side analysts anticipate that Morgan Stanley will post 7.32 earnings per share for the current year.
Morgan Stanley Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Thursday, October 31st were given a $0.925 dividend. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.82%. Morgan Stanley’s dividend payout ratio is currently 56.32%.
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Recommended Stories
- Five stocks we like better than Morgan Stanley
- Do ETFs Pay Dividends? What You Need to Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is a Dividend King?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Investing in Commodities: What Are They? How to Invest in Them
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.